Scrip is part of Informa PLC

This site is operated by a business or businesses owned by Informa PLC and all copyright resides with them. Informa PLC’s registered office is 5 Howick Place, London SW1P 1WG. Registered in England and Wales. Number 8860726.

This copy is for your personal, non-commercial use. For high-quality copies or electronic reprints for distribution to colleagues or customers, please call +44 (0) 20 3377 3183

Printed By

UsernamePublicRestriction
UsernamePublicRestriction

Antares Pharma Inc.

www.antarespharma.com

Latest From Antares Pharma Inc.

Finance Watch: Gene Therapy, Targeted Oncology Driving IPOs Despite Biopharma Stock Shakiness

Public Company Edition: Jefferies report notes robust IPO market, but SVB Leerink predicts a financing slowdown. Also, Mirati raises cash for KRAS programs after Amgen's ASCO data and a strategic shift results in job cuts at ImmunoGen.

Financing Deals

Keeping Track: Resubmissions For Tlando And Twirla NDAs, And A BTD For Pomalyst

The latest drug development news and highlights from our US FDA Performance Tracker.
Drug Review Regulation

Pediatric Testosterone Therapy: Sponsors Wary Of Trials Despite PREA

Studies are unfeasible, sponsors argue in advance of US advisory committee meeting that could lead to FDA ending its waiver on requiring clinical trials in pediatric patients for new testosterone replacement therapy products.
Advisory Committees Clinical Trials

Pipeline Review: Large Potential Overactive Bladder Population Beckons

Fourteen drugs are in clinical development for overactive bladder, most of which are early-to-mid stage and oral.

Gynecology & Urology Market Intelligence
See All

Company Information

  • Industry
  • Medical Devices
  • Pharmaceuticals
    • Drug Delivery
      • Controlled Release
      • Topical Delivery
      • Transdermal
  • Therapeutic Areas
  • Gynecological, Urological
  • Metabolic Disorders
  • Alias(es)
  • Medi-Ject Corp.
  • Ownership
  • Public
  • Headquarters
  • Worldwide
    • North America
      • USA
  • Parent & Subsidiaries
  • Antares Pharma Inc.
  • Senior Management
  • Robert Apple, Pres. & CEO
    Fred M Powell, EVP, CFO
    Greg DeFilippis, VP, Bus. Dev. & Alliances
    Edward Kessig, VP, Sales
    James Tursi, MD, EVP, Head, R&D & CMO
  • Contact Info
  • Antares Pharma Inc.
    Phone: (609) 359-3020
    100 Princeton S., Ste. 300
    Ewing, NJ 08628
    USA
Advertisement
Advertisement
UsernamePublicRestriction

Register